A medical device designer and maker has secured two manufacturing contracts worth £3 million over the next two years.

Integrated Technologies Ltd, known as ITL, has renewed a long-standing production deal with Scottish firm DySIS Medical Ltd and landed a £2 million agreement with Trek Diagnostics, now owned by ThermoFisher Scientific.

The Ashford-based company works with start-ups, spin-outs and established companies at various stages of product development, from conceptualisation through to full-scale manufacturing.

Its contract with DySIS Medical is for a medical device that removes subjectivity from the diagnosis of cervical cancer and other cervical abnormalities.

ITL developed the first commercially available DySIS Video Colposcope in 2010 and remains the sole manufacturer.

The Trek Diagnostics deal will see it make the ARIS 2X, a benchtop incubating and reading system used in veterinary and microbiology laboratories for antimicrobial resistance.

ITL chief executive Tom Cole said: “We are delighted to win these manufacturing contracts for 2016.

“We are pleased to be working in partnership with these two globally-recognised companies that are pioneers in the development of medical and IVD devices.

“Working with Dysis and Trek has been a really positive experience and we value the opportunity to work with them longer term.”